Business

Phio Announces Positive New Data Validating the INTASYL™ Immunotherapy Platform's Ability to Develop Novel Compounds Capable of Inhibiting Cancer Tumor Growth

Animal studies show a complete and statistically significant

articlePhio Pharmaceuticals Corp.March 31, 20203/company/phio-pharmaceuticals-corp/news/phio-announces-positive-new-data-validating-the-intasyltm-immunotherapy-platforms-ability-to-develop-novel-compounds-capable-of-inhibiting-cancer-tumor-growth

Phio Announces Positive New Data Validating the INTASYL™ Immunotherapy Platform's Ability to Develop Novel Compounds Capable of Inhibiting Cancer Tumor Growth

About this update from Phio Pharmaceuticals Corp.

[{"type":"text","content":"Animal studies show a complete and statistically significant (p","length":67,"tagName":"div"}]

More updates from Phio Pharmaceuticals Corp.